Lynsey Barber reports on BenevolentAI office opening in New York
BenevolentAI, one of the world’s largest private AI companies, today announced it is expanding its footprint in the United States by opening an office in New York City and has made two significant hires - Keith Hall, from Google, and Daniel Neil, from the Institute of Neuroinformatics, that will form the foundation of the new New York BenevolentAI team.
Nanalyze includes BenevolentAI in its round up of computational drug discovery start-ups using AI.
London, 11 April 2017 – BenevolentAI, a British artificial intelligence company, today announced that it has partnered with MRC Technology (“MRCT”), a medical research charity, to explore drug discovery initiatives in the field of small molecules and antibodies.
The Financial Times takes a look at the work we’re doing at BenevolentAI to “revolutionise medical research” after speaking to Co-Founder and Director, Ken Mulvany.